Article
Anti-PCSK9 antibodies for the treatment of heterozygous familial hypercholesterolemia: patient selection and perspectives.
Vascular health and risk management - 1 Jan 2017
Catapano Alberico Luigi, Pirillo Angela, Norata Giuseppe Danilo
Abstract excerpt
Heterozygous familial hypercholesterolemia (FH) is a genetic disorder characterized by high low-density lipoprotein cholesterol levels from birth, which exposes the arteries to high levels of atherogenic lipoproteins lifelong and results in a significantly increased risk of premature cardiovascular events. The diagnosis of FH, followed by an appropriate and early treatment is critical to reduce the cardiovascular...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.